Finally, another treatment that involves GRP78 is the antimalarial agent chloroquine, which has also been shown to sensitize GBM cells to TMZ and whose effects were further enhanced by GRP78 knockdown (89). This evidence concerns the gene HSPA5 and glioblastoma.